Article
Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
BMC infectious diseases - 3 Mar 2013
Simonella Leonardo M, Lewis Hazel, Smith Megan, Neal Harold, Bromhead Collette, Canfell Karen
Abstract excerpt
BACKGROUND: The national Human Papillomavirus (HPV) Immunisation Programme in New Zealand was introduced in 2008, and involves routine vaccination of girls 12-13 years with a catch-up for females aged up to 19 years. The aims of this study were to measure the pre-vaccination prevalence of oncogenic HPV infection in women aged 20-69 years who were participating in the New Zealand National Cervical Screening...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
